Genetic models of PD can replicate familial forms of the disease with known mutations in PD genes such as PARK7, LRRK2, PRKN, PINK1 or SCNA. Furthermore, transgenic models can be generated to examine genes of interest thought to be involved in PD pathogenesis. This evidence concerns the gene PINK1 and Parkinson disease.